Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 211 results found. Search for [ Cadila Healthcare ]

Results 1 to 21 of 211
E Kumar Sharma
January 17, 2020
The Indian Pharmaceutical Alliance in its statement released on 15 January said: There was no discussion at all on the alleged bribes being given by pharma companies to doctors as being reported in the media


PB Jayakumar
December 30, 2019
The USFDA's Office of Manufacturing Quality (OMQ) at the Centre for Drug Evaluation Research (CDER) evaluates compliance with cGMP for drugs based on inspection reports and evidence gathered by USFDA investigators


BusinessToday.In
December 30, 2019
Share Market Update: BSE Sensex ended 17 points lower at 41,558 and Nifty closed 14 points higher at 12,260.


PTI
New Delhi, December 22, 2019
The executives stressed on the need for Indian manufacturing to become globally competitive and join global value chain as the key ingredients for becoming a $5 trillion economy


BusinessToday.In
December 20, 2019
Cadila Healthcare share price rose up to 2.52% to Rs 268.15 compared to the previous close of Rs 261.55 on BSE


BusinessToday.In
December 20, 2019
Share Market Update: Benchmark indices Sensex and Nifty ended the week on a bullish note and closed in the green on Friday.


BusinessToday.In
November 21, 2019
Cadila Healthcare share price has lost 29% in one year and fallen 27% since the beginning of this year


BusinessToday.In
November 14, 2019
Following the acquisition of the remaining 15% stake each in its subsidiaries Zydus Technologies Ltd and Zydus Noveltech Inc, the two companies will become wholly-owned subsidiaries of Cadila Healthcare Ltd


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
New Delhi, November 4, 2019
SPARC Q2 results: Total income declined sharply by 70.49 per cent to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period


BusinessToday.In
November 4, 2019
The USFDA warning letter will not affect the existing business of Cadila Healthcare in the US and the existing product supplies from the Moraiya facility will continue


BusinessToday.In
November 4, 2019
Cadila Healthcare share which opened at Rs 257 against previous close of Rs 255.30 hit an intra day high of Rs 260.6 (2.08%)


BusinessToday.In
November 4, 2019
HDFC Q2 results: The total revenue from operations increased by 10.35 per cent to Rs 10,478.33 crore in Q2FY20 from Rs 9,494.70 crore in Q2FY19


PB Jayakumar
New Delhi, September 24, 2019
Ranitidine, an old molecule with sales of $412.4 million is found to have cancer-causing impurities


BusinessToday.In
New Delhi, August 12, 2019
RIL Annual General Meeting: Mukesh Ambani's statement comes days after Prime Minister Narendra Modi called on businesses to invest in J&K and Ladakh


PTI
August 9, 2019
Drug firm Cadila Healthcare on Friday reported a consolidated net profit of Rs 303.6 crore for the quarter ended June 30, 2019.


E Kumar Sharma
New Delhi, August 8, 2019
Given the low cost of electricity, favourable weather conditions and water availability, industry players feel that Jammu & Kashmir can be an important manufacturing hub of pharmaceutical companies


Gina S Krishnan
New Delhi, July 27, 2019
If the entrepreneur, the leader of the idea has the ability to accept reality, change direction or even perhaps to solve a related problem, it makes for a rare combination


PB Jayakumar
New Delhi, July 22, 2019
Zydus Cadila, India's fourth-largest drug company by revenue, is banking big on research of new drugs, even though others have bowed out. Zydus expects the new drug business to grow to Rs 3,500 crore in four-five years


PAGES 1 OF 11  12345